Plasma ddPCR for the detection of MET amplification in advanced NSCLC patients: a comparative real-world study
Sign Up to like & getrecommendations! Published in 2024 at "Therapeutic Advances in Medical Oncology"
DOI: 10.1177/17588359241229435
Abstract: Background: Mesenchymal–epithelial transition (MET) amplification is a crucial oncogenic driver and a resistance mechanism to epidermal growth factor receptor tyrosine kinase inhibitors (TKIs) of non-small-cell lung cancer (NSCLC). Fluorescence in situ hybridization (FISH) is the… read more here.
Keywords: nsclc patients; detection; plasma ddpcr; met amplification ... See more keywords